Citations

Showing 10 of 108119 citations.

The influence of the blood–brain barrier in the treatment of brain tumours
Rathi, Sneha , Griffith, Jessica I. , Zhang, Wenjuan , Zhang, Wenqiu , Oh, Ju‐Hee , Elmquist, William F. , Zhang, Wenqiu , Zhang, Wenjuan , Zhang, Wenqiu , Talele, Surabhi , Sarkaria, Jann N.

Mayo Clinic

Journal of Internal Medicine | January 18, 2022 | Volume: 292 | Issue: 1 | Pages: 3-30

10.1111/joim.13440 | PMID 35040235 Get It

AbstractBrain tumours have a poor prognosis and lack effective treatments. The blood–brain barrier (BBB) represents a major hurdle to drug delivery to brain tumours. In some locations in the tumour, the BBB may be disrupted to form the blood–brain tumour barrier (BBTB). This leaky BBTB enables diagnosis of brain tumours by contrast enhanced magnetic resonance imaging; however, this disruption is heterogeneous throughout the tumour. Thus, relying on the disrupted BBTB for achieving effective drug concentrations in brain tumours has met with little clinical success. Because of this, it would be beneficial to design drugs and drug delivery strategies to overcome the ‘normal’ BBB to effectively treat the brain tumours. In this review, we discuss the role of BBB/BBTB in brain tumour diagnosis and treatment highlighting the heterogeneity of the BBTB. We also discuss various strategies to improve drug delivery across the BBB/BBTB to treat both primary and metastatic brain tumours. Recognizing that the BBB represents a critical determinant of drug efficacy in central nervous system tumours will allow a more rapid translation from basic science to clinical application. A more complete understanding of the factors, such as BBB–limited drug delivery, that have hindered progress in treating both primary and metastatic brain tumours, is necessary to develop more effective therapies.
Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2‐negative individuals who had genetic testing in a large urban comprehensive cancer center
Tatineni, Sushma , Tarockoff, Meri, Abdallah, Nadine , Purrington, Kristen S. , Assad, Hadeel , Reagle, Rachel, Petrucelli, Nancie , Simon, Michael S. , Purrington, Kristen S

Mayo Clinic

Cancer Medicine | January 18, 2022 | Volume: 11 | Issue: 6 | Pages: 1465-1473

10.1002/cam4.4541 | PMID 35040284 Get It

AbstractBackgroundThere is sparse clinical information on the racial and ethnic distribution of results of multigene panel testing among individuals at high risk for hereditary cancer.MethodsWe evaluated the results of multigene panel testing across eight clinical sites across the state of Michigan for individuals seen for genetic counseling from May 13, 2013 to October 31, 2019 at the Karmanos Cancer Institute's cancer genetics clinic. We estimated the prevalence of pathogenic variants and variants of uncertain significance (VUS) from genes other than BRCA1/2 among individuals of non‐Hispanic White (NHW), Black or African American (AA), Ashkenazi Jewish (AJ), Arab, Hispanic, and other ancestry.ResultsThe racial and ethnic distribution of 2419 individuals who had panel testing included 68.8% NHW, 22.1% AA, 2.3% Arab, 2.2% AJ, 1.0% Hispanic, and 3.6% other. Of these, 11.2% had pathogenic variants and 17.5% had VUS. After multivariable analyses, compared to NHW, AA were less likely to have pathogenic variants (OR 95% CI, 0.38, 0.24–0.59, p < 0.001). Both AA and Arabs were more likely to have VUS (OR 95% CI, 1.53, 1.18–1.98, p = 0.001 and OR 95% CI, 2.28, 1.17–4.43, p = 0.015, respectively). There were no significant differences for other groups. The most common pathogenic variants were CHEK2 (n = 65), MUTYH (n = 45), ATM (n = 28), and MSH2 (n = 22); the most common pathogenic variants by race and ethnicity were CHEK2 (NHW), MSH2 and MUTYH (AA), MSH2 (Arab), MSH6 and CHEK2 (AJ), and MLH1 (Hispanic); the most common pathogenic variants by primary cancer site were CHEK2 (breast), MSH2 (colon), BRIP1 and MUTYH (ovarian), and MSH2 and MSH6 (endometrial).ConclusionsUnderstanding the racial and ethnic distribution of pathogenic variants in multi‐gene panels has the potential to lead to better identification of individuals at risk for hereditary cancer.
Optimizing the nutrition support care model: Analysis of survey data
Mundi, Manpreet S. , Mechanick, Jeffrey I. , Patel, Jayshil J. , Bonnes, Sara L. , Blackmer, Allison B. , Christian, Vikram J. , Hennessy, Sara A. , Jain, Ajay K. , Kaspar, M., Katz, Jennifer , Labossiere, Reginald, Limketkai, Berkeley N. , Morrison, Chet A. , Newberry, Carolyn , Mohamed Elfadil, Osman , Patel, Jayshil J , Christian, Vikram J , Hurt, Ryan T. , Jain, Ajay , Limketkai, Berkeley N , Morrison, Chet A , Pimiento, Jose M , Rosenthal, Martin , Taylor, Beth , McClave, Stephen A , Mechanick, Jeffrey I. , Mundi, Manpreet S , Elfadil, Osman Mohamed , Kaspar, Matthew B., Katz, Jennifer, McCarthy, Paul Joseph , Pimiento, José M. , Rosenthal, Martin D. , Taylor, Beth , McClave, Stephen A.

Mayo Clinic

Journal of Parenteral and Enteral Nutrition | January 18, 2022 | Volume: 46 | Issue: 7 | Pages: 1709-1724

10.1002/jpen.2326 | PMID 35040154 Get It

AbstractBackgroundMalnutrition is underrecognized and underdiagnosed, despite high prevalence rates and associated poor clinical outcomes. The involvement of clinical nutrition experts, especially physicians, in the care of high‐risk patients with malnutrition remains low despite evidence demonstrating lower complication rates with nutrition support team (NST) management. To facilitate solutions, a survey was designed to elucidate the nature of NSTs and physician involvement and identify needs for novel nutrition support care models.MethodsThis survey assessed demographics of NSTs, factors contributing to the success of NSTs, elements of nutrition education, and other barriers to professional growth.ResultsOf 255 respondents, 235 complete surveys were analyzed. The geographic distribution of respondents correlated with population concentrations of the United States (r = 90.8%, p < .0001). Most responding physicians (46/57; 80.7%) reported being a member of NSTs, compared with 56.5% (88/156) of dietitians. Of those not practicing in NSTs (N = 81/235, 34.4%), 12.3% (10/81) reported an NST was previously present at their institution but had been disbanded. Regarding NSTs, financial concerns were common (115/235; 48.9%), followed by leadership (72/235; 30.6%), and healthcare professional (HCP) interest (55/235; 23.4%). A majority (173/235; 73.6%) of all respondents wanted additional training in nutrition but reported insufficient protected time, ability to travel, or support from administrators or other HCPs.ConclusionCore actions resulting from this survey focused on formalizing physician roles, increasing interdisciplinary nutrition support expertise, utilizing cost‐effective screening for malnutrition, and implementing intervention protocols. Additional actions included increasing funding for clinical practice, education, and research, all within an expanded portfolio of pragmatic nutrition support care models.
Hepatology Highlights
Watkins, Ryan , Ilyas, Sumera I. , Penrice, Daniel D. , Conboy, Caitlin B. , Ayares, Gustavo , Arab, Juan Pablo

Mayo Clinic

Hepatology | January 17, 2022 | Volume: 75 | Issue: 2 | Pages: 241-242

10.1002/hep.32295 Get It

Current status and trends in subspecialty certification in physical medicine and rehabilitation
Sabharwal, Sunil , Kinney, Carolyn L. , Raddatz, Mikaela M. , Driscoll, Sherilyn W. , Francisco, Gerard E. , Robinson, Lawrence R. , Geis, Carolyn, Micheo, William , Robinson, Lawrence R , Kinney, Carolyn

Mayo Clinic

PM&R | January 17, 2022 | Volume: 15 | Issue: 2 | Pages: 212-221

10.1002/pmrj.12763 | PMID 35038251 Get It

AbstractBackgroundThere is a need to better understand the overall state of sub‐specialization in physical medicine and rehabilitation (PM&R).ObjectiveTo examine the status and trends in subspecialty certification for each of the seven subspecialties approved for American Board of Physical Medicine and Rehabilitation (ABPMR) diplomates.Design/SettingRetrospective analysis of deidentified information from the ABPMR database.ParticipantsPhysicians certified by ABPMR through 2019.InterventionsNot applicable.Main Outcome MeasuresFor each subspecialty, we examined: (1) the number of certificates issued to ABPMR diplomates; (2) the recertification rate; (3) the yearly trends for total active, new, and expired certificates; and (4) for ABPMR‐administered subspecialties, recertification rates for those entering the subspecialty through fellowship completion versus a “grandfathered” practice pathway.ResultsOf 11,421 ABPMR diplomates in the United States in 2019, a total of 3560 (31.2%) had 3985 active subspecialty certificates. Pain Medicine (PM) was the most common subspecialty certification (15.5% of all ABPMR diplomates) followed by Sports Medicine (SM, 6.6%), Brain Injury Medicine (BIM, 4.8%), Spinal Cord Injury Medicine (SCIM, 4.2%), Pediatric Rehabilitation Medicine (PRM, 2.5%), Neuromuscular Medicine (NMM, 0.7%), and Hospice and Palliative Medicine (HPM, 0.5%). For diplomates with more than one subspecialty certification, PM and SM was the most frequent combination. Both the recertification rate and the end of practice track eligibility influenced certification trends differently for individual subspecialties. The average number of new certificates added annually for every subspecialty was higher before than after the temporary practice track‐based eligibility ended; the difference was statistically significant (p < .05) for SCIM, PM, SM, and NMM. The recertification rate for all subspecialties combined was 73.4%. For the subspecialties (SCIM, PRM) for which these data were available, fellowship candidates had higher recertification rates than those grandfathered through a practice track.ConclusionThis report informs stakeholders about the state and evolution of subspecialty certification in PM&R over time.
Practical guidance for telemedicine use in neuro-oncology
Dunbar, Erin, Gan, Hui , Kurz, Sylvia C. , Mandel, Jacob , Mohile, Nimish, Nevel, Kathryn , Taylor, Jennie , Ullrich, Nicole J. , Welch, Mary , Wasilewski, Andrea , Mrugala, Maciej , Kurz, Sylvia , Strowd, Roy E. , Jordan, Justin T.

Mayo Clinic

Neuro-Oncology Practice | January 17, 2022 | Volume: 9 | Issue: 2 | Pages: 91-104

10.1093/nop/npac002 | PMID 35371525 Get It

AbstractWhile the COVID-19 pandemic has catalyzed the expansion of telemedicine into nearly every specialty of medicine, few articles have summarized current practices and recommendations for integrating virtual care in the practice of neuro-oncology. This article identifies current telemedicine practice, provides practical guidance for conducting telemedicine visits, and generates recommendations for integrating virtual care into neuro-oncology practice. Practical aspects of telemedicine are summarized including when to use and not use telemedicine, how to conduct a virtual visit, who to include in the virtual encounter, unique aspects of telehealth in neuro-oncology, and emerging innovations.
Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications
Fonkoua, Lionel Aurelien Kankeu , Usón, Pedro Luiz Serrano , Mody, Kabir , Roberts, Lewis R. , Kankeu Fonkoua, Lionel A, Serrano Uson Junior, Pedro Luiz, Roberts, Lewis R , Uson, Pedro L S , Mahipal, Amit , Borad, Mitesh J.

Mayo Clinic

Expert Opinion on Therapeutic Targets | January 17, 2022 | Volume: 26 | Issue: 1 | Pages: 79-92

10.1080/14728222.2022.2029412 | PMID 35034558 Get It

Current salvage therapies in Hodgkin lymphoma
Chohan, Karan, Ansell, Stephen M., Chohan, Karan , Chohan, Karan L , Chohan, Karan, Ansell, Stephen M.

Mayo Clinic

Leukemia & Lymphoma | January 17, 2022 | Volume: 63 | Issue: 6 | Pages: 1267-1280

10.1080/10428194.2021.2024819 | PMID 35037568 Get It

More Than Skin Deep: Dermatologic Conditions in Athletes
Costa, Lorena M.C., Clapp, Adrianna D.M. , Presutti, R. John , Sluzevich, Jason C. , Clapp, Adrianna D, Presutti, Richard J , Sluzevich, Jason C , Clapp, Adrianna , Pujalte, George G.A.

Mayo Clinic

Sports Health: A Multidisciplinary Approach | January 17, 2022 | Volume: 15 | Issue: 1 | Pages: 74-85

10.1177/19417381211065026 | PMID 35034516 Get It

Context: Athletes are a unique group of patients whose activities, particularly in high-contact sports such as wrestling and football, place them at high risk of developing skin conditions. The correct diagnosis of sports dermatoses requires familiarity with their clinical characteristics. It is critical that primary care physicians recognize the most common skin disorders to provide prompt treatment and prevent transmission. Evidence Acquisition: The Mayo Clinic library obtained articles from 2012 onward related to dermatologic conditions in athletes. Study Design: Review article. Level of Evidence: Level 3. Results: Dermatologic diseases in athletes are often infectious and contagious due to close-contact sports environments. Sports-related dermatoses include bacterial infections, such as impetigo, ecthyma, folliculitis, abscesses, furuncles, carbuncles, erysipelas, and cellulitis; fungal infections, such as tinea and intertrigo; viral infections, such as herpes, verrucae, and molluscum contagiosum; and noninfectious conditions, such as acne, blisters, and contact dermatitis. Conclusion: This article aims to address the manifestations of the most common cutaneous diseases in athletes on the first primary care visit. It discusses the appropriate tests and most recent evidence-based treatments for each ailment. It also addresses return-to-play recommendations related to the guidelines and regulations of selected sports organizations in the United States. Strength of Recommendation Taxonomy (SORT): C.
Seasonal Accumulated Workloads in Collegiate Women’s Soccer: A Comparison of Starters and Reserves
Jagim, Andrew R. , Askow, Andrew T. , Carvalho, Victoria , Murphy, Jason, Luedke, Joel, Erickson, Jacob L. , Luedke, Joel A, Jagim, Andrew R , Askow, Andrew T

Mayo Clinic

Journal of Functional Morphology and Kinesiology | January 16, 2022 | Volume: 7 | Issue: 1 | Pages: 11

10.3390/jfmk7010011 | PMID 35076561 Get It

Research quantifying the unique workload demands of starters and reserves in training and match settings throughout a season in collegiate soccer is limited. Purpose: The purpose of the current study is to compare accumulated workloads between starters and reserves in collegiate soccer. Methods: Twenty-two NCAA Division III female soccer athletes (height: 1.67 ± 0.05 m; body mass: 65.42 ± 6.33 kg; fat-free mass: 48.99 ± 3.81 kg; body fat %: 25.22 ± 4.78%) were equipped with wearable global positioning systems with on-board inertial sensors, which assessed a proprietary training load metric and distance covered for each practice and 22 matches throughout an entire season. Nine players were classified as starters (S), defined as those playing >50% of playing time throughout the entire season. The remaining 17 were reserves (R). Goalkeepers were excluded. A one-way ANOVA was used to determine the extent of differences in accumulated training load throughout the season by player status. Results: Accumulated training load and total distance covered for starters were greater than reserves ((S: 9431 ± 1471 vs. R: 6310 ± 2263 AU; p < 0.001) and (S: 401.7 ± 31.9 vs. R: 272.9 ± 51.4 km; p < 0.001), respectively) throughout the season. Conclusions: Starters covered a much greater distance throughout the season, resulting in almost double the training load compared to reserves. It is unknown if the high workloads experienced by starters or the low workloads of the reserves is more problematic. Managing player workloads in soccer may require attention to address potential imbalances that emerge between starters and reserves throughout a season.